Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin”

1,119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,119 results

Very early researchStudy completedNCT01184885
What this trial is testing

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Who this might be right for
Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 7
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Early research (Phase 1)Study completedNCT00003207
What this trial is testing

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

Who this might be right for
SarcomaUnspecified Adult Solid Tumor, Protocol Specific
Washington University School of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT00575406
What this trial is testing

Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 94
Testing effectiveness (Phase 2)UnknownNCT02953184
What this trial is testing

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Who this might be right for
Antineoplastic Combined Chemotherapy Protocols
Jilin University 160
Not applicableStudy completedNCT05959889
What this trial is testing

Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer

Who this might be right for
Breast CancerDoxorubicin Induced Cardiotoxicity
Damanhour University 50
Testing effectiveness (Phase 2)UnknownNCT03420014
What this trial is testing

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

Who this might be right for
Leiomyosarcoma
Philogen S.p.A. 114
Testing effectiveness (Phase 2)Study completedNCT03268382
What this trial is testing

P53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246

Who this might be right for
High-grade Serous Ovarian Cancer
Aprea Therapeutics 36
Not applicableStudy completedNCT02548780
What this trial is testing

LifePearl-Doxo Pharmacokinetic (PK) Study

Who this might be right for
HCCHepatocellular Carcinoma
Terumo Europe N.V. 15
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)UnknownNCT00392340
What this trial is testing

Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group 63
Testing effectiveness (Phase 2)Study completedNCT00006125
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology
Early research (Phase 1)WithdrawnNCT01333423
What this trial is testing

Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT03983096
What this trial is testing

Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 1,213
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT03639246
What this trial is testing

Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Aravive, Inc. 53
Early research (Phase 1)Study completedNCT00000954
What this trial is testing

Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00484432
What this trial is testing

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer

Who this might be right for
Ovarian Cancer Metastatic Recurrent
AGC Biologics S.p.A. 37
Testing effectiveness (Phase 2)Study completedNCT00003352
What this trial is testing

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 89
Early research (Phase 1)Study completedNCT00011414
What this trial is testing

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

Who this might be right for
Wilms' TumorSarcomaAdenaocortical Carcinoma+2 more
National Cancer Institute (NCI) 29
Load More Results